Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3Bijal Shah, Olalekan O. Oluwole, Jae H. Park et al.|Leukemia|2025Cited by 35